Surgical Treatment for Neuropathic Pain - Printer-friendly version

Treatment of Neuropathic Pain: Opioids, Cannabinoids, and Topical Agents - Printer-friendly version

1. To review the mechanisms and eff ects of opioids, cannabinoids, and topical agents in neuropathic pain. 2. To review clinically relevant pharmacokinetics and pharmacodynamics of opioids, cannabinoids, and topical agents in patients with neuropathic pain. 3. To review the clinical evidence for the use of opi-oids, cannabinoids, and topical agents in neuro-pathic pain.

Laboratory Tools and their Relevance for Assessing Patients with Neuropathic Pain - Printer-friendly version

1. Describe neurophysiological techniques for assessing peripheral and central somatosensory pathways in patients with neuropathic pain. 2. Describe the use of skin biopsy for assessing so-matosensory pathways in patients with neuropathic pain.

Interventional and Nonpharmacological Therapies for Neuropathic Pain - Printer-friendly version

The Pathophysiology of Neuropathic Pain: Critical Review of Models and Mechanisms - Printer-friendly version

1. Understand the defi nition and frontiers of neuropathic pain (NP). 2. Describe the link between NP and lesions of nociceptive systems. 3. Differentiate among the different animal models of NP. 4. Have a broad understanding of diff erent peripheral, spinal, and supraspinal mechanisms relevant to NP. 5. Describe the diffi culties in relating these mechanisms to pain in humans. 6. Translate som...

Treatment of Neuropathic Pain: Antiepileptic and Antidepressant Drugs - Printer-friendly version

Neuropathic Pain Neuropathic pain was originally defi ned by the International Association for the Study of Pain (IASP), in 1994, as “pain initiated or caused by a primary lesion or dysfunction in the nervous system” [57]. In 2008, Treede et al. proposed a redefi nition to “pain arising as a direct consequence of a lesion or disease aff ecting the somatosensory system” [78]. Since then, the IAS...